Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v24-FR Version v8-EN
Language French English
Date Updated 2022-02-28 2021-11-16
Drug Identification Number 02141019 02141019
Brand name CALCIUM GLUCONATE INJECTION, USP 10% CALCIUM GLUCONATE INJECTION, USP 10%
Common or Proper name Calcium Gluconate Injection, USP 10% 100 mg/mL SD Vial (Plastic) 100 mL Calcium Gluconate Injection, USP 10% 100 mg/mL SD Vial (Plastic) 100 mL
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients CALCIUM GLUCONATE CALCIUM GLUCONATE
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 100 mL 100 mL
ATC code B05BB B05BB
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-11-01 2021-11-01
Actual start date 2021-02-01 2021-11-01
Estimated end date 2022-03-07 2021-12-31
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Effective Mar. 7, 2022, 100mL will be used to cover 100% of 100mL demand plus 100% of 50mL demand on a mL per mL basis for contract customers. Please see customer communication. Allocation strategy implemented to stretch inventory and ensure equitable distribution. Please see customer communication.
Health Canada comments